Preferred Label : Vitiligo-associated multiple autoimmune disease susceptibility 1;
Symbol : VAMAS1;
CISMeF acronym : SLEV1; VAMAS1; VTLG;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Vitiligo; Systemic lupus erythematosus, vitiligo-related; VTLG; SLEV1;
Description : Generalized vitiligo is an autoimmune disease characterized by melanocyte loss, which
results in patchy depigmentation of skin and hair, and is associated with an elevated
risk of other autoimmune diseases. It is a genetically complex disorder involving
multiple susceptibility genes and unknown environmental triggers. Patients with generalized
vitiligo have elevated frequencies of other autoimmune diseases, suggesting that these
diseases involve shared genetic components (summary by Jin et al., 2010). - Genetic
Heterogeneity of Vitiligo-Associated Multiple Autoimmune Disease Susceptibility Additional
forms of vitiligo-associated multiple autoimmune disease susceptibility have been
mapped to chromosomes 1p31 (VAMAS2, 607836, associated with mutation in the FOXD3
gene, 611539), 7 (VAMAS3; 608391), 8 (VAMAS4; 608392), 4 (VAMAS5; 609400), and 6p21.3
(VAMAS6; 193200).;
Prefixed ID : #606579;
Origin ID : 606579;
UMLS CUI : C1847835;
Automatic exact mappings (from CISMeF team)
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
Validated automatic mappings to NTBT